Abstract
More than 22 million people globally suffer from the rapidly worsening condition, congestive heart failure (CHF).In those with impaired left ventricular (LV) dysfunction, cardiac resynchronization therapy (CRT) is clinically effective in about 70% of the patients. CRT can improve exercise capacity and well-being of the patient, minimize re-hospitalization and potentially, lower mortality.
References
- McAlister F, Wiebe N, Abraham W. Cardiac Resynchronization Therapy in Heart Failure. Annals of Internal Medicine. 2005; 142(4):307.
- Nauffal V, Zhang Y, Tanawuttiwat T, Blasco-Colmenares E, Rickard J, Marine J et al. Clinical decision tool for CRT-P vs. CRT-D implantation: Findings from PROSE-ICD. PLOS ONE. 2017;12(4):e0175205.
- Jaswal A, Khalil S. CRT AND Combo Devices – Who Needs Them and When?. medicine update. 2010;20.
- Gregoratos G, Abrams J, Epstein A, Freedman R, Hayes D, Hlatky M et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article. Circulation. 2002;106(16):2145-2161.
- Bradley D, Bradley E, Baughman K. Cardiac resynchronization and death from progressive heart failure. a meta-analysis of randomized controlled trials. ACC Current Journal Review. 2003;12(3):81-82.
- Young J, Abraham W, Smith A. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure. the MIRACLE ICD trial. ACC Current Journal Review. 2003; 12(5):68-69.
Corresponding Author
Dr Subramanyam
Department of General Medicine and Cardiology, K.S. Hegde Medical Academy, Deralakatte, Mangalore
DOI: https://dx.doi.org/10.18535/jmscr/v8i3.62
